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  The role of the physiotherapist in Huntington’s disease develops in response to the clinical need 
over the prolonged course of the illness; it is important for physiotherapists to consider the cost 
implications of their services throughout a lifelong disease. 
  Physiotherapy management should be tailored to the stage of the disease, but also importantly to 
specific signs and symptoms that affect functional performance and life participation; treatment-
based classifications can be used to better categorize patient problems and guide specific 
physiotherapy interventions. 
  Physiotherapy management should begin soon after diagnosis, with a focus on encouraging an 
active lifestyle, and maximizing and maintaining physical functioning.
  Early referral enables practitioners to determine a baseline for the person with Huntington’s disease, 
and supports the establishment of a therapeutic relationship between the person with Huntington’s 
disease, practitioners and caregivers.
  During early and middle stages of the disease, physiotherapy evaluation should include measures 
to aid in clinical decision making, including identification of common impairments, such as 
bradykinesia, dystonia and postural imbalances. 
  Therapists should consider use of responsive clinical measures to aid in outcomes assessment and 
falls risk assessment, utilizing tools such as the Berg Balance Scale, Tinetti Mobility Scale, Timed Up 
and Go Test and measures of gait speed.
  Towards the middle to end stages, therapists should work in collaboration with other healthcare 
professionals to achieve the best possible quality of life for patients and their families; therapists 
have an important role in advising on seating and positioning and respiratory management, as well 
as relaxation techniques.
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Huntington’s disease (HD) is a degenerative 
neurological disease that results in a triad of clinical 
symptoms, encompassing motor, behavioral 
and cognitive impairments. Researchers have 
developed a better understanding of the complex 
nature of the movement disorder in this disease, 
however, to date, physiotherapy intervention is 
not provided consistently [1]. The beneficial role 
of physiotherapy for people with Parkinson’s 
disease, a basal ganglia disorder with some similar 
features to HD, has been previously illustrated, 
with two recent systematic reviews reporting 
that physiotherapy can improve multiple factors, 
including physical functioning, health-related 
quality of life (HR-QoL), strength, balance 
and gait [2,3].
The literature in support of physiotherapy for 
people with HD is less clear. Two reviews have 
noted that to date there has been only a small 
amount of evidence in support of physiotherapy 
within HD [4,5]. Although the impact of currently 
available literature is somewhat overshadowed by 
poor methodological rigor, small sample sizes, 
unclear selection criteria (resulting in potential 
heterogeneity in participant groups) and a lack 
of follow-up, there have more recently been 
some optimistic developments. For example, 
a before–after trial with a sample size of 40 
found an intensive rehabilitation program 
of six sessions per week demonstrated an 
improvement in motor function over the 2-year 
period [6,7]. Positive findings from environmental 
enrichment studies in mice also provide some 
support for the role of physiotherapy for HD. In 
mice models of HD, those mice placed within 
an environment providing physical, mental 
and social stimulation, have a slower disease 
progression, and maintain motor function for 
longer compared with those housed in more 
isolated conditions [8,9]. 
People with HD have a range of physical, 
cognitive, psychological and social care needs 
over an extended time frame. One of the 
difficulties in developing clinical guidelines for 
complex neurodegenerative diseases, such as 
HD, is the heterogeneity of clinical signs and 
symptoms. While staging of the disease process 
(e.g., early, middle, late) can provide a general 
framework for intervention, within each stage 
there is a wide range of potential impairments 
that can impact on an individuals’ level of 
functional activity and life participation. This 
makes structuring of consistent therapeutic 
approaches problematic. This problem is not 
unique to HD and has been documented in 
other physiotherapy patient groups, most notably 
low back and neck dysfunction, and for general 
neurorehabilitation patient groups [10–15]. 
sUMMarY Background: Physiotherapy may provide a means of delaying onset or 
progression of Huntington’s disease (HD), resulting in improved daily functioning and quality 
of life. Physiotherapy is being more frequently recommended for people with HD, but there 
have been no specific guidelines published for implementation of a structured physiotherapy 
program. The Physiotherapy Working Group (PWG) of the European Huntington’s Disease 
Network (EHDN) set out to develop a comprehensive Guidance Document for physiotherapists 
to provide best practice guidelines. Methods: A review of the literature was conducted 
using a systematic approach. There was insufficient literature in support of physiotherapy 
interventions and approaches to be able to conduct a complete evidenced-based review, 
therefore, physiotherapy expert subgroups were formed to incorporate consensus as to best 
practice. A draft document was distributed to the entire membership of the working group, 
to outside physiotherapists and other healthcare professionals within EHDN to elicit feedback 
and comments. results: A Guidance Document covering eight specific areas pertaining to 
physiotherapy management of HD was developed. In order to facilitate the document’s 
practical usability among clinicians, a treatment-based classification system is proposed to 
categorize patients based on presenting signs and symptoms, and provide a foundation for 
development of a more standardized intervention approach. Discussion: The Physiotherapy 
Guidance for HD is a comprehensive, consensus- and evidence-based document that can be 
used by physiotherapists to implement a plan of care that is currently consistent with best 
practice for individuals at all stages of HD. As evidence becomes available, future systematic 
reviews will be required in order to inform further development. The use of treatment-based 
classifications, which aim to better categorize common signs and symptoms and link them 
to appropriate intervention plans, may be useful in relatively rare diseases, such as HD, to aid 
clinical reasoning and promote effective outcome evaluation. 
Physiotherapy guidance & treatment-based classifications for people with HD sPecial rePort
future science group www.futuremedicine.com 13
Researchers have advocated that by creating 
sub-classifications of patients’ impairments and 
problems, and matching those with more specific 
interventions, therapists may improve outcomes 
in their patients [10–12,15]. These researchers 
have argued that in order for therapists to 
develop consistent approaches to common 
patient problems, so that the efficacy of any one 
approach can be tested, better categorization as 
described above is required. Opinions differ as to 
whether this categorization should come in the 
form of a movement-based system (i.e., based on 
specific movement problems only), or one which 
assesses a wider range of signs and symptoms. 
Regardless, the resultant categorization can 
provide the foundation for development of a 
more standardized intervention approach.
Clinical guidelines are evidence-based 
recommendations for clinical practice in 
specific conditions [16,17]. The availability of 
clinical guidelines facilitates uniformity of 
care and standards of practice with the aim of 
improving quality of care provision. Availability 
of appropriate guidelines can change the process 
and practice of care for the benefit of the patient 
and can inform the research process, leading to 
more effective research into practice. 
It is critically important for health professionals 
to be able to define and document their 
evaluation practices and intervention strategies, 
so that systematic outcome evaluation can be 
done and best practice highlighted. Clinical 
guidelines are in place for physiotherapy in other 
neurodegenerative diseases, such as Parkinson’s 
disease [13,18] and multiple sclerosis [19]. While 
physiotherapy is increasingly being proposed 
as a mode of intervention for people with HD, 
to date there has been no formalized clinical 
guidelines or standards of care to guide practice. 
The Physiotherapy Working Group (PWG) of 
the European Huntington’s Disease Network 
(EHDN), therefore, set out to develop a guidance 
document to provide a written framework for the 
physiotherapeutic management of people with 
HD. The aims were to provide, where possible, 
a scientific evidence-based document to inform 
the optimal, individualized physiotherapeutic 
management of people with HD. This included 
the provision of a written framework for the 
physiotherapeutic management of people with 
HD, in order to enable uniformity of care 
internationally. We also aimed to highlight the 
scientific evidence for physiotherapy practice with 
people with HD, evaluating the effectiveness 
of any intervention strategies presented in the 
literature. A guidance document would allow 
practitioners to make an informed decision 
regarding patient care and to highlight areas 
within practice that currently lack the scientific 
evidence base to inform future research. 
Methods
The Physiotherapy Guidance Document for HD 
was created through a combination of available 
scientific evidence and expert consensus. A 
PICO (Population, Intervention, Comparison, 
and Outcome) approach to searching the 
literature was used. The population was defined 
as people with HD. The intervention was any 
physiotherapy-based intervention or assessment. 
No set comparisons were made or follow-up 
times set. Outcomes were any reliable and valid 
measure of physiotherapy-related interventions.
Databases searched were Ovid MEDLINE® 
1950 to March Week 2 2009; EMBASE 
1980 to 2009 (Week 12, 21 March); EBSCO 
CINAHL 1981 to 21 March 2009; PEDro 
1929 to 21 March 2009. Search terms included: 
Huntington’s disease, chorea, Huntington, 
Huntington chorea ; physica l therapy 
modalities, physiotherapy, rehabilitation, 
occupational therapy, physical activity, exercise 
therapy, activities of daily living/activities 
of daily living, physical mobility, muscle 
stretching exercises/stretching, respiratory 
therapy/respiratory therapy, flexibility, range of 
motion, range of movement, upper extremity/
upper limb, reaching, reach, grasping, grasp, 
reach to grasp, posture, balance, accidental 
falls/falls, equipment and supplies/equipment, 
seating, positioning, transfers, functional 
status, gait. 
Inclusion criteria were: articles published in 
English; therapy in human HD subjects only; 
subjects to be of 18 years of age and with a con-
firmed diagnosis of HD; study specific to physi-
otherapy/occupational therapy/rehabilitation 
and exercise. A total of 239 individual papers 
were identified through database searching. A 
total of 206 of these were excluded, leaving a 
total of 33 papers for review. The main reasons 
for exclusion were for non-human studies, sub-
jects did not have HD, and the study was not 
related to physiotherapy/occupational therapy/
rehabilitation or exercise. This left a total of 31 
papers for review in the full guidance document. 
Two of these were not retrieved and 33 were 
summarized in the full guidance document. 
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Three reviews, nine physiotherapy-related 
studies, 11 gait-specific, one muscle strength, 
three balance and mobility, one dystonia, two 
upper limb-specific and one paper regarding 
m ultisensory stimulation were identified. 
The identified evidence was summarized 
independently and then discussed at a EHDN 
PWG meeting. This summary is presented in 
the final guidance document. Owing to the 
paucity of scientific evidence, recommendations 
were also formulated based on expert consensus 
from the EHDN PWG. Following completion 
of the initial draft document, the Guidance 
Document was disseminated to all members 
of the PWG and other interested healthcare 
professionals. Amendments were made to 
the document based on their feedback. In a 
second phase of development, sections of the 
Guidance Document were reviewed in detail 
by subgroups of two to three members of the 
PWG. Feedback from the subgroups were 
directed back to the authors, and integrated 
into the final document. 
Following publication and dissemination of 
the Guidance Document, the PWG met and 
discussed the impact of the document and 
provided constructive feedback. A consensus 
was reached that the next step in development 
of Guidance for Physiotherapists was to provide 
more specific guidelines within a user-friendly 
format. The requirements for a subsequent 
document were that it had a simple, organized 
structure that made it readily useful to novice 
therapists, but one that would not be limiting 
or overly prescriptive for more experienced 
clinicians. The methodology provided by 
treatment-based classification systems was an 
obvious choice for structuring such guidance. 
The group agreed that current research in the 
area of treatment-based classification [10–12,15] 
had potential for application to the HD 
population. We therefore proposed a range of 
treatment-based classifications to address the 
heterogeneity of patient conditions, to provide 
structure for standardized data collection of 
interventions and outcomes, and consequently 
inform evaluation of complex interventions 
and advance research into care and evidence-
based service delivery for people with HD. A 
second subgroup was subsequently formed, 
consisting of expert physiotherapists within 
HD and neurodegenerative diseases. Two 
focus group meetings of this group were 
held over a 6-week period, during which 
time treatment-based classif ications were 
constructed using the Guidance Document as 
a template for discussions. An iterative process 
was undertaken where key impairments were 
classified, so that the key signs and symptoms 
commonly found in HD could be organized 
within a classification system. The discussions 
also focused on linking these classifications with 
specific interventions and outcome measures 
from the Guidance Document. 
Results
  Physiotherapy guidance for HD
The review of the literature revealed a lack of 
any well-controlled randomized intervention 
studies of physiotherapy interventions in HD 
that could be used to conduct a systematic 
review. We considered all relevant literature and 
case reports, as well as observational studies that 
were identified in the review to provide some 
insight as to the nature of the impairments 
that could provide a theoretical foundation 
and recommendations for physiotherapy 
interventions. Alongside this process of reviewing 
the literature, we consulted with expert clinicians 
to finalize our recommendations. 
A brief overview of the philosophy and 
recommendations for developing physiotherapy 
plans as well as considerations of procedural 
interventions is presented. Here we report the 
summary recommendations. Greater detail on 
each topic as well as the review of the literature 
can be found in the formal physiotherapy 
guidance document [101].
Framework for patient management
An important component to patient 
management in a neurodegenerative disease 
such as HD is to consider people at all stages 
of the condition, including those who have the 
mutation for HD but are not displaying motor 
symptoms (pre-manifest) [1,20]. It is further 
suggested that physiotherapy management of 
people with HD should be modified according 
to individual problems and to the stage of the 
disease. The reader is referred to the original 
paper where the framework development is 
described [1]. Currently, intervention focuses 
on symptomatic management, however, there 
is increasing support for early intervention 
where an impact may be made on biological 
processes with the potential to influence the 
natural history of the condition. In addition, 
early referral to physiotherapy for people with 
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HD may be beneficial in a number of ways. It 
enables practitioners to ascertain a baseline for 
the person with HD, supports the establishment 
of a therapeutic relationship between the 
person with HD, practitioners and caregivers, 
and ensures early intervention to attempt to 
maintain mobility and function for as long as 
possible [1]. 
Evaluation & outcome measures
The physiotherapy evaluation for people with 
HD should be both anticipatory and responsive 
to the disease stage. The physiotherapist should 
work in collaboration with the patient and 
evaluate their individual considerations [21]. 
The WHO International Classif ication of 
Functioning, Disability and Health (ICF) [22] can 
aid assessment of a person’s level of functioning, 
and further facilitate consideration of the triad of 
motor, cognitive and psychiatric symptoms that 
are often seen in HD. It can also be used for goal 
setting and treatment planning, and focuses on 
aspects of a person’s health and health-related 
wellbeing in terms of activities and participation, 
that is, the description of the tasks (activities) 
and/or life situations (participation) the person 
wishes to be involved in, and the impact that 
impaired body function or structure is having 
on these aspects.
A structured evaluation for the patient 
with HD is comprised of both subjective 
and objective assessments, the primary goal 
being to determine the relationship between 
any impairments, activity l imitations 
and participation restrictions. Caregiver 
involvement, wherever possible, is strongly 
encouraged, particularly if the patient has 
difficulties communicating through cognitive or 
physical impairment. The objective evaluation 
should include assessment of neuromuscular 
(e.g., bradykinesia, dystonia, chorea), 
musculoskeletal (e.g., posture, range of motion, 
pain, muscle strength) and cardiorespiratory 
and cardiovascular impairments (e.g., vital 
signs, breathing function, exercise capacity). 
Standardized tests can be utilized as outcome 
measures that may be sensitive to changes 
related to any physiotherapy intervention. The 
Berg Balance Scale, Tinetti Mobility Scale, 
Timed Up and Go Test, Four square step 
test and the Functional Reach Test have all 
been found to be valid and responsive clinical 
measures in HD and are considered useful to 
detect those at risk of falls [23–26].
Physiotherapy interventions
Since pharmacologic interventions to date have 
been ineffective in altering or slowing the disease 
process, healthcare practitioners and patients 
themselves continue to look for alternative 
therapies. While physiotherapy has been shown to 
be of benefit for some neurodegenerative diseases, 
such as Parkinson’s disease and multiple sclerosis, 
the evidence supporting its use for people with 
HD is limited. Nonetheless, utilizing traditional 
physiotherapy techniques with applicability to 
the special needs of this population may provide 
some benefit for a disease that currently lacks any 
effective treatment regimes. 
The main goals of physiotherapy intervention 
will generally change over time. In the early stages, 
interventions will be primarily preventative. As 
the disease progresses, interventions become 
restorative in nature, addressing specific physical 
impairments and resulting activity limitations. 
In the later stages, intervention is primarily 
compensatory, in which therapists develop 
strategies to maximize a patient’s functional 
ability despite progression of the disease. With 
regards to falls risk, a clear justification of benefit 
of any particular management strategy compared 
to the risk that the situation presents should be 
elucidated. Therapists working with people 
with HD should acknowledge and facilitate 
independent mobility for as long as is reasonably 
possible [1]. 
Goals should be specific and measurable 
and mutually agreeable to both the patient 
and therapist [27]. They should address specific 
functional problems or participation restrictions 
that are amenable to physiotherapy intervention. 
Goals to decrease chorea or dystonia, for example, 
may not be realistic. Furthermore, amelioration 
of any particular impairment in HD may not 
translate into functional improvements and, 
therefore, therapists should focus on functional 
gains while attempting to ascertain the influence 
various impairments have on activity limitations 
in each of their patients. 
Similar to healthy individuals, exercise, 
including strengthening and cardiovascular 
conditioning, is recommended for people who 
are pre-manifest and in the early stages of the 
disease. Exercise may be helpful in minimizing 
any neuromuscular or musculoskeletal effects 
that come with disease progression. As the 
disease progresses and specific problems become 
evident, therapists must begin to ascertain those 
impairments that may be contributing to specific 
Neurodegen. Dis. Manage. (2012) 2(1) future science group16
sPecial rePort Quinn & Busse
activity limitations or participation restrictions. 
For example, involuntary movements could 
contribute to balance problems, but inactivity 
may also be a contributing factor. Impairment-
based diagnoses that may impact on function 
include: dystonia; bradykinesia; moderate-to-
severe chorea or ballismus; rigidity; impaired 
respiratory function and fatigue. It is important 
to manage the secondary effects of such 
impairments. For example, for patients with 
chorea, protective equipment can be provided, 
and for patients with dystonia, loss of range 
of motion and muscle imbalance should be 
prevented. Functional problems that may occur 
include: impaired fine motor skills and manual 
dexterity, impaired sitting posture and sitting 
ability, impaired mobility, transfers and gait; 
impaired balance/and risk of falls and reduced 
cardiovascular and general physical f itness 
[1,23–25]. In general, it is thought that physical 
fitness plays a part in a patient’s motivation to 
keep as active as possible and their ability to cope 
with more challenging treatment interventions. 
The potential impact of psychiatric impairments 
and a patient’s cognitive status cannot be 
overlooked. Therapists should consider whether 
or not a patient has memory loss, depression, 
aggression, obsessive–compulsive tendencies or 
anxiety, to name a few, and these impairments 
must be taken into account during the design of 
any intervention plan [28].
Documentation & interdisciplinary 
management
Developing and documenting a plan of care 
for the patient with HD should also include 
coordination of services and communication 
that needs to take place with other professionals, 
caregivers or family members so that the 
physiotherapy plan can be implemented. This 
may also include referrals to other professionals 
and additional documentation of any planned 
home program and patient/caregiver education. 
Importantly, the physiotherapist should be part 
of an interdisciplinary team that is involved in the 
management of patients with HD throughout the 
lifespan of their disease. Such professionals include 
geneticists, neurologists, nurses, occupational 
therapists, psychologists, speech language 
therapists and social workers, among others. It 
is critical for therapists to consider collaboration 
with these professionals and to understand their 
role as part of an interdisciplinary team and in 
particular their contribution to palliative care in 
the late stages of the disease. The ultimate aim 
for palliative care is to achieve the best possible 
quality of life for patients and their families [29]. 
The physiotherapist can advise on seating and 
positioning, respiratory management as well 
as relaxation techniques and may also have a 
role to play when considering advanced care 
directives [30]. 
Cost implications
It is also important for physiotherapists to 
consider the cost implications of their services 
throughout a life-long disease. It is unreasonable 
to expect that any funding agency (government 
or otherwise) would be agreeable to ongoing 
physiotherapy intervention two- to three-times 
a week for the extended disease process. Instead, 
therapists should consider serving consultative 
roles to patients from an early stage, and 
providing more intensive intervention when a 
change in functional status warrants it. 
Treatment-based classifications
Seven treatment-based classifications specific to 
HD have been developed using the Guidance 
Document as a reference point. The primary 
findings discussed above for the Guidance 
Document were utilized to categorize patients 
more specifically based on primary impairments 
and activity limitations (Table 1). Within 
each classification, we determined signs and 
symptoms as a method for categorization. We 
then listed general aims, and provided specific 
intervention strategies and outcome measures. 
Examples of classifications are available from 
the authors, and will be made available in full 
on the EHDN website in due course. Clinical 
validation of these classifications is currently 
underway across the EHDN network. 
Dissemination
In order to implement and achieve standardization 
of practice, the PWG decided that it was critical 
for this work to be made freely available and 
shared as widely as possible. This was important 
also to elicit feedback from physiotherapists and 
other healthcare professionals working in the 
field. We therefore published 2000 print copies of 
the Guidance Document, which were distributed 
to all EHDN sites, physiotherapy education 
programs in the UK, HD Associations across 
Europe, and to other clinical and academic sites 
upon request. This work has also been presented 
at numerous conferences as well as family and 
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healthcare professional information days across 
the UK and Europe. 
Discussion
While physiotherapy is increasingly being 
considered an important mode of intervention 
for people with HD, to date there has been no 
formalized guidance or standards of care to 
document best practice. A need was identified 
from within the HD community to first and 
foremost conduct pragmatic analysis of current 
physiotherapy service delivery in HD, and to 
document the available evidence related to 
physiotherapy services. This paper describes the 
process and outcomes from the development 
of these clinical guidelines for physiotherapy 
management of people with HD. 
Owing to the progressive nature of HD, the 
needs of people with this condition change over 
time, and the role of the physiotherapist should 
be flexible in response to the clinical need over 
the prolonged course of the illness. Although 
the evidence supporting physiotherapy 
interventions for people with HD is limited, 
there is some suggestion from HD literature 
and from other similar neurodegenerative 
diseases that exercise and other physiotherapy 
strategies may be useful in minimizing 
the effects of this devastating disease. The 
Physiotherapy Guidance Document has been 
developed based on expert consensus and 
available evidence, and is freely available to the 
HD community. It does, however, continue to 
be a work in progress and will require review 
and updating as new more robust research 
becomes available. 
The availability of a guidance document 
is the first step towards standardization of 
physiotherapy practice. We must however 
highlight that the background research done 
to support the guidance document yielded a 
paucity of applicable research studies, and no 
randomized controlled trials aimed at evaluating 
the efficacy of physiotherapy or exercise. The 
challenge of evaluating physiotherapy is largely 
due to problems of identifying, documenting 
and reproducing the multiple components of 
the intervention. The randomized controlled 
trial was originally developed for evaluation 
of single interventions, such as a particular 
drug, and is not fully compatible with complex 
interventions, such as physiotherapy. It is clear 
that rigorous evaluation of complex interventions 
such as physiotherapy is imperative to their 
continued existence, but this requires a phased 
approach that can ultimately lead to a definitive 
controlled trial [31]. The Medical Research 
Council Framework for evaluation of complex 
interventions refers to a theoretical and a 
modeling stage prior to conducting full-scale 
randomized controlled clinical studies [31]. The 
first step is to review the relevant theory and 
literature that is available to ensure best design 
of intervention; this is called the theoretical 
phase. The next modeling phase involves 
identifying components of the intervention of 
choice (based on the previous theoretical stage) 
and determining how the outcomes would be 
Table 1. Seven treatment-based classifications developed for physiotherapy management of people with Huntington’s disease.
Classification Description of clinical findings Stages of disease
A. Exercise capacity and 
performance
Absence of motor impairment; potential for cognitive and/or behavioral issues Presymptomatic/early
B. Planning and sequencing of 
tasks (including bradykinesia)
Difficulty and slowness in performing functional activities (e.g., dressing, bathing, 
ADLs or sit to stand). Presence of apraxia or impaired motor planning; slowness of 
movement and/or altered force generation capacity
Early-mid
C. Mobility, balance and  
falls risk
Ambulatory for community and/or household distances; balance, strength or 
fatigue resulting in falls or high risk for falls
Early-mid
D. Secondary adaptive changes 
and deconditioning
Musculoskeletal and/or respiratory changes resulting in decreased participation in 
daily activities
Early-mid
E. Abnormal posturing (seating 
and bed positioning; manual 
handling)
Inappropriate alignment due to adaptive changes, involuntary movement, inability 
to facilitate or coordinate movement
Mid-late
F. Respiratory dysfunction Impaired respiratory function and capacity; limited endurance; impaired airway 
clearance; risk for infection
Mid-late
G. Palliative care Unable to ambulate; dependent for most ADLs; difficulty maintaining upright 
sitting position; range of motion and pulmonary issues
Late
ADL: Activities of daily living.
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achieved. It is clear that mixed methodology 
incorporating both quantitative and qualitative 
methods are relevant to these initial stages. The 
Guidance Document developed for HD used this 
phased approach and provides a starting point 
for the theoretical and modeling components 
of the framework. It provides the foundations 
for development of future physiotherapy-related 
controlled trials. 
Development of treatment-based classifications 
as an extension of the Guidance Document 
can help to further facilitate standardization of 
practice. This approach requires an expansion and 
some modification of the conceptual framework 
presented [1], which bases intervention strategies 
on stages of the disease [1,20]. Treatment-based 
classifications address the issue of heterogeneity 
within HD by targeting specific problems that 
are seen irrespective of stage of disease. This 
allows for a more individualized approach to 
patient management but incorporates a clear 
structure for evaluation of efficacy.
Limitations, implications & 
future directions
The development of this Guidance Document 
and the subsequent classification system is the 
first step in the process towards solidifying the 
evidence base in physiotherapy in HD. The 
literature review for this document was limited 
to English-speaking articles, and thus should 
be a starting point for a more extensive multi-
language search. An important next step is clinical 
validation and revision of the classifications, in 
an effort to promote standardization of care. 
Once standardization of care is achieved, we can 
take the next important step in evaluating the 
efficacy of our interventions through pragmatic 
controlled clinical trials. 
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